UNSPSC 51391722: Levarterenol or noradrenaline or norepinephrine

This classification denotes a catecholamine with the molecular formula C8H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X4W3ENH1CV, chemically known as 1,2-benzenediol, 4-(2-amino-1-hydroxyethyl)-, (s)- but generally known as noradrenaline, which bears US NIH Compound Identifier 951. European Medicines Agency schedules Noradrenaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09360MIG.

The term NOREPINEPHRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules noradrenaline in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: C1=CC(=C(C=C1C(CN)O)O)O.

UNSPSC 51391722 Levarterenol or noradrenaline or norepinephrine is a Commodity code that shows minimal relevant recent activity aligned with its nominal scope. The two recent state and local opportunities tagged to this code — Seminole County's procurement of Naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs — fall outside the specific pharmaceutical agent this code names and instead address broader pharmaceutical procurement and opioid-response initiatives. State and local buyers use the code nominally for epinephrine and related sympathomimetic agents used in emergency medical response, critical care, and anaesthesia contexts, but the recent solicitations do not target this category.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2026; this procurement is potentially FEMA-funded and requires E-Verify compliance, workers' compensation insurance, and commercial general liability coverage. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to solicit vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information on vendors' experience with direct contracting for self-insured employers and health plans, negotiated net pricing models, and outcomes-based agreements. The code shows no recent activity that tracks levarterenol or norepinephrine procurement by state departments, counties, cities, school districts, transit authorities, or other local public bodies. If your firm supplies these agents to hospital systems, emergency medical services, or critical-care networks, monitor for direct procurements by state health departments or regional trauma systems rather than expect activity under this UNSPSC code in the near term.